• Sustainability
  • DE&I
  • Pandemic
  • Finance
  • Legal
  • Technology
  • Regulatory
  • Global
  • Pricing
  • Strategy
  • R&D/Clinical Trials
  • Opinion
  • Executive Roundtable
  • Sales & Marketing
  • Executive Profiles
  • Leadership
  • Market Access
  • Patient Engagement
  • Supply Chain
  • Industry Trends

Pharma Pulse 4/2/24: Bird Flu in Texas, Anxiety/Depression Treatment Linked with Heart Disease Outcomes & more


The latest news for pharma industry insiders.

Tackling Patient-Related Challenges Along the Pharma Supply Chain

Syneos Health's Kim Plesnarski uncovers the key issues that customers are currently trying to address, including the retail shift from small-molecule products to biologics.

Study: Anxiety, Depression Treatment Linked With Heart Disease Outcomes

Investigators aimed to determine the impact of psychotherapy or psychopharmacologic treatments on adverse outcomes in individuals with coronary artery disease or heart failure.

Person Infected With Bird Flu in Texas After Contact With Cattle

The case adds another worrying wrinkle to a global outbreak that has devastated bird and marine mammal populations, and recently appeared in cattle herds.

Bayer Appoints Sue Ann Pentecost as Vice President, Head of U.S. Pharmaceutical Communications

Bayer has announced Sue Ann Pentecost as the new Vice President, Head of Pharmaceuticals Communications in the United States. She will report directly to Beth Roden, Senior Vice President, Head of Communications for Bayer US, and Head of Communications Bayer Consumer Health NA. Pentecost succeeds Lori Moore, retiring the end of May.

InCrowd Inc on LinkedIn:

Harnessing the power of Pharma to combat physician burnout! Check out this new article in Pharmaceutical Executive from Apollo Intelligence CEO & President, Daniel S. Fitzgerald. #HealthcareMarketResearch

Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor Miranda Schmalfuhs